Article Information
History
- April 13, 2021.
Article Versions
- Version 1 (December 7, 2020 - 11:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andrew Lee*,1,
- Xin Yang*,1,
- Jonathan Tyrer2,
- Aleksandra Gentry-Maharaj3,
- Andy Ryan3,
- Nasim Mavaddat1,
- Alex P. Cunningham1,
- Tim Carver1,
- Stephanie Archer4,
- Goska Leslie1,
- Jatinderpal Kalsi5,6,
- Faiza Gaba7,
- Ranjit Manchanda7,8,
- Simon A. Gayther9,
- Susan J. Ramus10,11,
- Fiona M. Walter4,
- Marc Tischkowitz12,
- Ian Jacobs5,10,
- Usha Menon3,
- Douglas F. Easton1,2,
- Paul P.D. Pharoah1,2 and
- Antonis C. Antoniou†,1
- 1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
- 2Centre for Cancer Genetic Epidemiology, Department of Oncology, The University of Cambridge, Cambridge CB1 8RN, UK
- 3MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, WC1V 6LJ, UK
- 4The Primary Care Unit, Department of Public Health & Primary Care, The University of Cambridge, Cambridge, CB1 8RN, UK
- 5Department of Women’s Cancer, Institute for Women’s Health, University College London, London, WC1E 6HU, UK
- 6UCL Research Department of Epidemiology & Public Health, University College London, London, WC1E 7HB, UK
- 7Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London, EC1M 6BQ, UK
- 8Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK
- 9Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 10School of Women’s and Children’s Health, Faculty of Medicine, University of New South Wales, Sydney 2052, Australia
- 11Adult Cancer Program, Lowy Cancer Research Centre, University of NSW, Sydney 2052, Australia
- 12Department of Medical Genetics and National Institute for Health Research, Cambridge Biomedical Research Centre, The University of Cambridge, Cambridge, UK
- ↵†Corresponding author:
Antonis C. Antoniou, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK, aca20{at}medschl.cam.ac.uk, +44 1223 748630
Posted April 13, 2021.
A Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors
